HPV-Related Anal Precancerous Lesions in MSM: A Comparative Study of PrEP Users and HIV-Positive Individuals
Clinical Infectious Diseases · 2026
DOI: 10.1093/cid/ciaf724 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Magali Surmont und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, UZ Brussel, Brussels, Belgium. Hauptthemen laut MEDLINE: Papillomavirus Infections, Homosexuality, Male, HIV Infections, Pre-Exposure Prophylaxis. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Although anal cancer is rare, it disproportionately affects high-risk groups such as men who have sex with men (MSM) and people with human immunodeficiency virus (HIV). MSM using Pre-Exposure Prophylaxis (MSM-PrEP) represent an emerging subgroup with behavioral risk factors that may increase susceptibility to High-Risk Human Papillomavirus (HRHPV) infection and anal High-grade Squamous Intraepithelial Lesions (HSIL). However, data on precancerous anal lesions in this group remain unexplored. This study aims to compare the prevalence and distribution of histological abnormalities detected by High-Resolution Anoscopy (HRA) between MSM-PrEP and MSM with HIV (HIV + MSM) and to explore the association between anal HSIL and anal swab results using cytology and HRHPV testing.
Methods
This secondary exploratory analysis extended a prospective, monocentric cross-sectional study on cytology and HPV infection conducted at the HIV Reference Centre and PrEP Clinic of Universitair Ziekenhuis Brussel by incorporating histological data.
Results
A total of 85 MSM-PrEP and 93 HIV + MSM underwent HRA. Histologically confirmed anal HSIL did not differ significantly between MSM-PrEP and HIV + MSM (OR 0.6, 95% CI .32–1.25). No significant variation was observed in the overall histological outcome distribution (P = .401). A history of gonorrhea was significantly associated with HSIL (OR 2.39, 95% CI 1.03–5.55). Cytology showed limited discriminatory value, while HRHPV infection was present in all HSIL cases. Many lesions were linked to HRHPV types other than HPV16.
Conclusions
MSM-PrEP may be at similarly high risk for anal HSIL as HIV + MSM, underscoring the need for tailored screening strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, UZ Brussel, Brussels, Belgium.
- Vrije Universiteit Brussel (VUB), Brussel, Belgium.
- Department of Dermatology, UZ Brussel, Brussels, Belgium.
- Department of Pathology, UZ Brussel, Brussels, Belgium.
- Centrum Voor Kankeropsporing, Brugge, Belgium.
- Department of Infectious Diseases, UZ Brussel, Brussels, Belgium.
ORCID-Profile: Magali Surmont, Michel Verheyden, Mathijs Goossens, Sabine Allard
Zitieren
APA
Surmont, M., Verheyden, M., Sahebali, S., Goossens, M., Allard, S., & Kindt, S. (2026). HPV-Related Anal Precancerous Lesions in MSM: A Comparative Study of PrEP Users and HIV-Positive Individuals. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf724
Vancouver
Surmont M, Verheyden M, Sahebali S, Goossens M, Allard S, Kindt S. HPV-Related Anal Precancerous Lesions in MSM: A Comparative Study of PrEP Users and HIV-Positive Individuals. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciaf724
BibTeX
@article{Surmont2026,
author = {Surmont, Magali and Verheyden, Michel and Sahebali, Shaira and Goossens, Mathijs and Allard, Sabine and Kindt, Sebastien},
title = {HPV-Related Anal Precancerous Lesions in MSM: A Comparative Study of PrEP Users and HIV-Positive Individuals},
journal = {Clinical Infectious Diseases},
year = {2026},
doi = {10.1093/cid/ciaf724}
}
EUVIMED